Literature DB >> 9244408

Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors.

L Tamagnone1, P M Comoglio.   

Abstract

Hepatocyte growth factor (HGF) is the prototype of a family of structurally related soluble molecules, named scatter factors (SFs). These control a complex genetic programme leading to cell-dissociation, migration in the extracellular matrix, growth, acquisition of polarity and tubule formation. This programme is pivotal during the embryonic development of epithelial and some mesodermal-derived tissues. In the adult HGF sustains cell survival and regeneration. A structurally related molecule, originally identified as macrophage stimulating protein (MSP), triggers the same complex genetic programme in epithelial and neural cells. The receptors for HGF and MSP are the tyrosine kinases encoded by the homologous genes MET and RON. As a distinctive feature, these receptors act via a two-phosphotyrosine docking site, capable of concomitant activation of multiple intracellular transducers and signalling pathways. In a number of malignant tumours, MET and RON constitutively sustain the genetic programme of scattering, leading to invasive growth and metastatic phenotype. Four MET-related receptors have been recently identified (the SEX protein family). These molecules are predominantly expressed during development and are likely to mediate repelling cues between cells of different type.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9244408     DOI: 10.1016/s1359-6101(97)00007-5

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  20 in total

Review 1.  Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis.

Authors:  J V Soriano; M S Pepper; L Orci; R Montesano
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

2.  Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.

Authors:  Apaporn Menakongka; Tuangporn Suthiphongchai
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

3.  Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide.

Authors:  J E Cartwright; D P Holden; G S Whitley
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

4.  Morphogenetic effects of neuregulin (neu differentiation factor) in cultured epithelial cells.

Authors:  A Chausovsky; I Tsarfaty; Z Kam; Y Yarden; B Geiger; A D Bershadsky
Journal:  Mol Biol Cell       Date:  1998-11       Impact factor: 4.138

5.  Expression of Hepatocyte Growth Factor (HGF) and its Receptor (MET) in Medullary Carcinoma of the Thyroid.

Authors:  Mauro Papotti; Martina Olivero; Marco Volante; Francesco Negro; Maria Prat; Paolo M. Comoglio; Maria Flavia DiRenzo
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

6.  Therapeutic evaluation of monoclonal antibody-maytansinoid conjugate as a model of RON-targeted drug delivery for pancreatic cancer treatment.

Authors:  Hang-Ping Yao; Liang Feng; Jian-Wei Zhou; Rui-Wen Zhang; Ming-Hai Wang
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

Review 7.  The role of hepatocyte growth factor in corneal wound healing.

Authors:  Hidetaka Miyagi; Sara M Thomasy; Paul Russell; Christopher J Murphy
Journal:  Exp Eye Res       Date:  2017-10-10       Impact factor: 3.467

8.  Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.

Authors:  Phillippa J Neville; David V Conti; Pamela L Paris; Howard Levin; William J Catalona; Brian K Suarez; John S Witte; Graham Casey
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

9.  Regulation of cell proliferation and migration in glioblastoma: new therapeutic approach.

Authors:  Yangjin Kim
Journal:  Front Oncol       Date:  2013-03-18       Impact factor: 6.244

10.  An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice.

Authors:  Massimiliano Mazzone; Cristina Basilico; Silvia Cavassa; Selma Pennacchietti; Mauro Risio; Luigi Naldini; Paolo M Comoglio; Paolo Michieli
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.